PubMed · 2004 · 22 citations · 0 references
Antifungal AgentVulvar DiseasesHealth SciencesUnderlying CausesAntifungal AgentsVaginitisGynecologyAbnormal Vaginal DischargeUrogynecologyIntravaginal UseInfection ControlMedicineClinical MicrobiologyAntimicrobial ResistanceFungal PathogenVaginal DischargeDrug Resistance
Antifungal medications for intravaginal use have been available in the United States for more than a decade. Women may be inclined to self-diagnose yeast infections with any vaginal discharge or other vulvovaginal symptoms that they deem abnormal. As we saw in the first part of this article, "Abnormal vaginal discharge: Using office diagnostic testing more effectively" (J Fam Pract 2004; 53[10]:805-814), abnormal discharge is more likely to be bacterial vaginosis or no pathogen at all. Potential delay in diagnosis and treatment of a sexually transmitted disease is also a concern. Increasing resistance of Candida sp. to imidazoles is associated with indiscriminate use of over-the-counter products.